Patents by Inventor Satya Srinivas Chetlapalli

Satya Srinivas Chetlapalli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PENCILLAMINE ORAL COMPOSITION
    Publication number: 20190282519
    Abstract: The Invention relates to an oral pencillamine composition for reducing the dosing frequency in treatment of cysteinuria comprising of therapeutically effective amount of pencillamine and one or more pharmaceutically acceptable excipients.
    Type: Application
    Filed: March 18, 2019
    Publication date: September 19, 2019
    Applicant: CRONUS RESEARCH LABS PRIVATE LIMITED
    Inventor: Satya Srinivas Chetlapalli
  • TIOPRONIN ORAL COMPOSITION
    Publication number: 20190282525
    Abstract: The invention relates to an oral tiopronin composition for reducing the dosing frequency in treatment of cysteinuria comprising of therapeutically effective amount of tiopronin and one or more pharmaceutically acceptable excipients.
    Type: Application
    Filed: March 18, 2019
    Publication date: September 19, 2019
    Applicant: CRONUS RESEARCH LABS PRIVATE LIMITED
    Inventor: Satya Srinivas Chetlapalli
  • ROOM TEMPERATURE STORAGE STABLE TRIENTINE COMPOSITION
    Publication number: 20190269628
    Abstract: The invention relates to a room temperature storage stable trientine composition comprising of pharmaceutically acceptable solid oral dosage form of trientine; and oxidation resistant container system. The invention also relates to a method of storing trientine solid oral composition at room temperature without degradation.
    Type: Application
    Filed: March 4, 2019
    Publication date: September 5, 2019
    Applicant: CRONUS RESEARCH LABS PRIVATE LIMITED
    Inventor: Satya Srinivas Chetlapalli
  • DAPTOMYCIN INJECTABLE FORMULATION
    Publication number: 20150216928
    Abstract: The present invention disclose a lyophilized pharmaceutical formulation comprising antibacterial agent, daptomycin as active and tocopheryl phosphate hydrolysate mixture with improved reconstitution time for parental administration and to the process of preparation thereof. Daptomycin is a cyclic lipopeptide antibacterial agent derived from the fermentation of Streptomyces roseosporus. The chemical name is N-decanoyi-L-tryptophyl-Dasparaginyl-L-aspartyi-L-threonylgly? D,-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanines 1-lactone.
    Type: Application
    Filed: August 22, 2013
    Publication date: August 6, 2015
    Applicant: AGILA SPECIAL TIES PRIVATE LIMITED
    Inventors: Satya Srinivas Chetlapalli, Srirama Sarveswara Rao Mandavilli, Babu Justin, Sathyanarayan Srinivas Meda
  • METHOD FOR TREATING VITILIGO WITH A PROSTAGLANDIN ANALOGUE
    Publication number: 20120251613
    Abstract: A method of stimulating melanogenesis in a skin surface of a patient, by treating the skin surface with a topical formulation comprising an effective amount of 17-phenyl-18,19,20-trinor-PGF2? ethyl amide in a dermatologically acceptable carrier. The topical formulation may be a cream, a gel, a lotion, a spray, an ointment, an aqueous solution, a nonaqueous solution, or a transdermal patch. The dermatologically acceptable carrier may contain an oily carrier or an aqueous carrier.
    Type: Application
    Filed: July 29, 2011
    Publication date: October 4, 2012
    Applicant: AGILA SPECIALITIES PVT. LTD.
    Inventors: Rajeev JAIN, Tarun Narang, Satya Srinivas Chetlapalli